Year XXIV, n. 1, January 2023 Effectiveness of escin/diethylammonium salicylate in reducing inflammation and alleviating pain: clinical cases Volume...
Issues
Numero speciale 1 – 2023 SPECIALE Expert consensus riguardante cannabis, cannabinoidi e prodotti derivati Focus sul cannabidiolo nell’epilessia Apri...
XXI г., No 2, февруари 2023 г. От лечение към грижи: ранни мултидисциплинарни подходи за лечение на пациенти с...
Year XXVI, N. 1, January 2023 Clinical effectiveness of switching from adalimumab to a biosimilar in Italian patients with...
Year XX, N. 7, December 2022 Cannabinoid Education 360° 8th EAN Congress Europe 2022 June 25-27 Vienna, Austria Apri...
Year XX, N. 6, December 2022 The vicious cycle in migraine progression: clinical challenges and raising the bar for...
Year XXV, N. 10, December 2022 A new medical device REF-FTP57 for the treatment of non-erosive reflux disease: a...
Anno XXV, N. 10, dicembre 2022 Biosimilari in diabetologia Edoardo Mannucci, Enrico Torre, Sergio Di Matteo, Chiara Martinotti Apri...
Anno XXVII, N. 6, Dicembre 2022 L’evoluzione storica nella classificazione dei farmaci per personalizzare le cure dei disturbi del...
